![]() ENTEROME Enterome is a company developing solutions in the field of diseases associated with abnormalities of the gut microbiome. | ![]() Q32 Bio Q32 Bio is a biotechnology company developing treatments for patients with severe autoimmune and inflammatory diseases. | Menten AI Menten AI is a drug discovery company that develops a generative AI platform for peptide therapeutics. | ![]() Adhesion Therapeutics Adhesion Therapeutics (also known as Celeris Therapeutics) is a company that designs molecular glue degraders. | ||
Founding Date | Founding Date 2020 | Founding Date 2011 | Founding Date N/A | Founding Date 2018 | Founding Date 2021 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Durham, US HQ | Locations Paris, FR HQ Évry, FR | Locations Cambridge, US HQ | Locations San Francisco, US HQ Toronto, CA | Locations Menlo Park, US HQ Graz, AT London, GB |
Employees | Employees 811% decrease | Employees 484% decrease | Employees 348% decrease | Employees 16 | Employees 433% decrease |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 52.3m (almost 6 years ago) | Latest funding round $ 60m (over 5 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 129.6m | Total funding raised $ 106m | Total funding raised N/A | Total funding raised N/A |

Enterome is a company developing solutions in the field of diseases associated with abnormalities of the gut microbiome.
View company
Q32 Bio is a biotechnology company developing treatments for patients with severe autoimmune and inflammatory diseases.
View companyMenten AI is a drug discovery company that develops a generative AI platform for peptide therapeutics.
View company
Adhesion Therapeutics (also known as Celeris Therapeutics) is a company that designs molecular glue degraders.
View company